Skip navigation

 Login or Register | Member Centre

Posted AT 1:57 PM EDT on 16/05/08

Reject a Melnyk slate, Biovail shareholders urged

Globe and Mail Update

Troubled drug maker Biovail Corp. is urging shareholders to reject any slate of dissident directors that its controversial estranged founder Eugene Melnyk may propose, saying the company's future is on the line.

The full text of this article has 443 words.

To continue reading this article, you will need to purchase this article.

Already have a member account? Login now

Pay-Per-View Offers To read the complete article, select one of the following options

Purchasing from globeandmail.com is quick and secure.

Single Article: $4.95

4-pack: $17.95

Back to top